LIRAGLUTIDE (Saxenda®)
Clinical Indication
Obesity as part of a tier 3 specialist weight management service
Comments
In line with NICE TA664
Date of classification
June 2017
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.